Pavel Hradílek

Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial

Diego Cadavid, Michelle Mellion, Raymond Hupperts et al. · The Lancet Neurology · 2019 · 173 citations

Neurological Disorder, Clinical Neurology, Clinical Trials +5

Distal enlargement of the optic nerve sheath in the hyperacute stage of intracerebral haemorrhage

David Školoudík, Roman Herzig, Táňa Fadrná et al. · British Journal of Ophthalmology · 2010 · 44 citations · Full text

Determination of chitinase 3-like 1 in cerebrospinal fluid in multiple sclerosis and other neurological diseases

Pavlína Kušnierová, David Zeman, Pavel Hradílek et al. · PLoS ONE · 2020 · 42 citations · Full text

Neurofilament levels in patients with neurological diseases: A comparison of neurofilament light and heavy chain levels

Pavlína Kušnierová, David Zeman, Pavel Hradílek et al. · Journal of Clinical Laboratory Analysis · 2019 · 39 citations · Full text

Assessment of Intrathecal Free Light Chain Synthesis: Comparison of Different Quantitative Methods with the Detection of Oligoclonal Free Light Chains by Isoelectric Focusing and Affinity-Mediated Immunoblotting

David Zeman, Pavlína Kušnierová, Zdeněk Švagera et al. · PLoS ONE · 2016 · 33 citations · Full text